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Abstract
The IAPE (Intracisternal A-type Particles elements with an Envelope) family of murine endogenous retroelements is present
at more than 200 copies in the mouse genome. We had previously identified a single copy that proved to be fully
functional, i.e. which can generate viral particles budding out of the cell and infectious on a series of cells, including human
cells. We also showed that IAPE are the progenitors of the highly reiterated IAP elements. The latter are now strictly
intracellular retrotransposons, due to the loss of the envelope gene and re-localisation of the associated particles in the
course of evolution. In the present study we searched for the cellular receptor of the IAPE elements, by using a lentiviral
human cDNA library and a pseudotype assay on transduced cells. We identified Ephrin A4, a GPI-anchored molecule
involved in several developmental processes, as a receptor for the IAPE pseudotypes. We also found that the other 4
members of the Ephrin A family –but not those of the closely related Ephrin B family- were also able to mediate IAPE cell
entry, thus significantly increasing the amount of possible cell types susceptible to IAPE infection. We show that these
include mouse germline cells, as illustrated by immunohistochemistry experiments, consistent with IAPE genomic
amplification by successive re-infection. We propose that the uncovered properties of the identified receptors played a role
in the accumulation of IAPE elements in the mouse genome, and in the survival of a functional copy.
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Introduction
Mammalian genomes are filled with numerous copies of mobile
genetic elements. Among them, endogenous retroviruses are the
remnants of infectious retroviruses that once infected the germline of
their host and have since then been transmitted from one generation
to the other following a mendelian pattern (reviewed in refs. [1–3]).
After this initial insertion within the genome, some of these elements
were recruited by their host and some of their open reading frames
changed into ‘‘ordinary’’ cellular genes which now fulfil physiological
functions, like the syncytingenes that are involved in the formation of
the placenta [4–8]. However, the bulk of these elements still behave
like transposons and increase their copy number after the initial
invasion of the germline. While doing so, they can cause insertional
mutagenesis, either by directly interrupting open reading frames or
by inducing dysregulations of cellular genes (reviewed in [3]).
The amplification is thought to have initially proceeded via
successive re-infections of the germline using a traditional extra-
cellular infection route. However, the most successful families of
elements (with regards to their copy number) identified so far have
switched to a strictly intracellular amplification mechanism that
does not require the viral particles to be exposed to the extra-
cellular compartment and that makes them much more efficient
(reviewed in [9,10]). This switch in the amplification strategy is
usually correlated to the loss of the envelope (env) gene that
encodes the membrane glycoprotein responsible for the binding
of the particle to a cellular protein used as a receptor, and a
modification of the intracellular trafficking of the particles via an
alteration of the N-terminal part of the structural Gag protein.
These changes can be seen in pan-mammalian ERV-L elements,
as well as in the mouse MusD and IAP (Intracisternal A-type
Particles) elements [10–12], and lead to an intracellularisation
of the elements. During the process, the latter increase their
amplification efficiency within their current host but completely
loose their autonomy, being unable of re-infection and direct
horizontal transfer, and thus cannot colonise new species anymore.
The mouse IAPE family is particularly interesting in this respect:
we previously demonstrated that it is the progenitor of the
intracellular IAP elements [10], which are probably the most
successful and active family of retrotransposons in the mouse,
being responsible for an estimated 10% of the de novo mutations
occurring in laboratory animals. But at the same time IAPEs
also survived as infectious elements, with an identified mouse
endogenous proviral copy being able to produce fully functional
particles that can re-infect a variety of cells from different species.
The IAPE family is for this reason quite special, since the
progenitors of the other widespread intracellularised elements
have disappeared from the genome of their host. We wondered
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particles, and tested this hypothesis by searching for the IAPE
cellular receptor.
Results
Screening of a lentiviral cDNA library
To identify the protein used as a receptor by the IAPE
endogenous retrovirus, we made use of a lentiviral cDNA library
generated from human Huh7 cells (see Methods). It was selected
because Huh7 cells can be infected by retroviral pseudotypes
carrying the IAPE Env (data not shown) and are therefore cer-
tain to express the IAPE envelope receptor. As schematised in
Figure 1A, these cDNA were introduced into simian Vero cells,
which are resistant to infection by the IAPE Env pseudotypes,
using VSV-G lentiviral pseudotypes at a multiplicity of infection
(MOI) of approximately 6. The cells were grown for 3 days to
allow expression of the transduced cDNAs before being submitted
to two cycles of infection by IAPE Env pseudotypes containing a
hygromycin resistance gene (final MOI estimated to be more than
1), or by control pseudotypes containing the hygromycin resistance
gene (hygroR) but with no envelope proteins. After three days of
amplification, the cells were submitted to hygromycin selection.
Because of the high background due to the infection protocol used
with the pseudotypes (high MOI and spinoculation), we obtained a
high number of hygroR clones, with no clear difference between
the IAPE Env and no Env pseudotype-infected cell populations.
This was not surprising since the theoretic frequency of cells
transduced by a given cDNA (approx. 1 out of 10,000 cells,
assuming all genes are equally expressed) is much lower that the
background level of infection (1 cell out of 100–1000). The clones
were thus subjected to a second round of selection using IAPE Env
pseudotypes encoding the red fluorescent protein mCherry that we
applied directly on the original plates (Figure 1A). The plates were
then manually screened for red fluorescence to identify clones
containing multiple (.10) independent infection foci. 42 such
clones were identified, grown individually and then assayed a third
time for their susceptibility to infection with IAPE Env using GFP-
containing pseudotypes. The 5 more infectable ones (IAPE Env
titre increased by 10–100 fold as compared to the parental Vero
cell line) were selected for further analysis of their Huh7-derived
cDNA content.
Ephrin A4 is a receptor for the IAPE envelope protein
To characterise the cDNA present in the selected clones, we
extracted their genomic DNA and total RNA and subjected them
to PCR/RT-PCR using primers located within the lentiviral
vector and surrounding the cDNA cloning sites. These PCR
analyses showed that all the selected clones contained more than
one cDNA, which was expected due to the high MOI used during
the cDNA library transduction. In addition, the 5 clones can be
split in two groups with regards to their cDNAs content, indicating
that these 5 clones originated from only two initial transduction
events. This is possible since the cells were amplified before they
were infected with the IAPE Env pseudotypes. Most of the cDNAs
we identified were not considered as potential receptors for the
IAPE Env, either because they were truncated at their 59 end and
did not contain a complete ORF, or because they corresponded to
soluble intracellular proteins. However, two of the clones con-
tained a full-length cDNA of TMEM9 (the gene for Transmem-
brane Protein 9) (clones number 2 and 3 in Figure 1B), while the
last three (number 1, 4 and 5) had been transduced with a cDNA
of EFNA4 (the gene for Ephrin A4), both of which encode
membrane-associated proteins.
TMEM9 was the less likely candidate, as it is described as a
strictly intracellular protein, associated with the endosomal mem-
branes [13] (see Figure 1B). In addition, qRT-PCR experiments
indicated that it is already moderately expressed in the paren-
tal Vero cells and that its expression was only increased by
approximately 4 times in one of the two clones containing its
cDNA, with its level being mostly unchanged in the four other
positive clones (Figure 1C). Its ectopic expression in Vero cells,
that we achieved either by transfection or by lentiviral transduc-
tion, did not render the cells susceptible to infection by the IAPE
Env pseudotypes (not shown), definitively demonstrating that
TMEM9 is not a receptor for the IAPE Env.
The other putative receptor we identified, Ephrin A4, was
a much better candidate. As with the other members of the
ephrin A family, it is a plasma membrane protein, attached by a
GlycosylPhosphatidylInositol (GPI) anchor, that can interact with
a set of integral membrane proteins called EphA (Ephrin A
receptor proteins) (Figure 1B). In vivo, these interactions are
widely used in developmental processes and axonal guidance
(reviewed in [14,15]). By qRT-PCR, we found that this gene is
poorly (if at all) expressed in the Vero cell line and its transcript
level is increased by 50–500 fold in the five clones we had
identified as positive for IAPE Env infection (Figure 1C). Using
specific primers in a PCR reaction performed on genomic DNA,
we checked that only three of these clones contained an EFNA4
cDNA, indicating that the other two (that possess the TMEM9
cDNA) had overexpressed their endogenous copy via an unknown
mechanism. All these findings made it a promising candidate as an
IAPE Env receptor. To test it directly, we overexpressed this gene
in Vero and WOP (a SV40-transformed murine fibroblast cell line)
cells, and tested if it made them more susceptible to infection by
IAPE Env-bearing pseudotypes containing either the GFP or the
LacZ reporter gene (see scheme in Figure 2A). As shown in
Figure 2B and C, these two cell lines are naturally resistant to
infection by the IAPE Env pseudotypes. However, the same cells
expressing Ephrin A4 (via a lentiviral vector) can be very efficiently
infected by the IAPE Env pseudotypes. This effect is specific, since
it did not make the Vero cells susceptible to infection by the Friend
Author Summary
In mammals, nearly half the genome is composed of
reiterated scattered sequences. Some of them, called
endogenous retroviruses, have a structure similar to that
observed for the integrated form of infectious retroviruses.
The current theory to account for their presence is that an
infectious retrovirus once infected the germline of its host.
This viral genome was then transmitted to the progeny
and expressed from there, producing new infectious parti-
cles, which could re-infect new germline cells and thus
increase the viral genomic copy number. However no
evidence has yet been provided to support this model. In
this study, we identify a family of five cellular proteins, the
Ephrin As, as receptors for a model mouse family of
endogenous retroviruses, the IAPE elements. We analyse
their expression pattern and show that both the oocytes
and some male germline cells express Ephrin A proteins
and can thus be infected by IAPE particles. This finding
strongly supports the current model of ERVs amplification.
In addition, the IAPE envelope ability to use five different
cellular receptors suggests that it might be impossible for
the host to evolve a resistance against this viral element,
and provides a clue on how the IAPE family survived so
long in the mouse genome.
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syncytin-2 (syn2) or xenotropic MLV (Xeno) Env pseudotypes. In
these two cell lines, the titre of VSV-G pseudotypes was not
modified, indicating that the gain in the IAPE Env titre is not due
to a general increase in the susceptibility of these cell lines to
lentiviral pseudotypes. This set of experiments indicated that the
EFNA4 cDNA we identified in the Vero clones is responsible for
their acquired susceptibility to IAPE Env pseudotypes.
We then constructed an expression vector for a His-tagged
soluble IAPE Env SU subunit, as previous studies with other
retroviral envelopes had shown that such constructs can be used to
stain cells expressing the cognate receptors [16,17]. In FACS
experiments, the IAPE soluble SU protein could only label WOP
cells that had been previously transduced with an expression
vector for Ephrin A4 (Figure 3A), whereas an irrelevant His-tagged
SU protein (derived from the syncytin1 envelope protein) did not
give any staining, consistent with these cells not expressing a
functional receptor for syncytin1. The specific staining observed
with the IAPE soluble SU protein indicates that the acquired
infectability of the Ephrin A4-expressing WOP cells by the IAPE
pseudotypes is linked to the ability of these cells to bind the
IAPE envelope protein. However this did not rule out that Ephrin
A4 could act as an intermediate, inducing the expression (or
potentially altering the subcellular localisation) of another protein
that would be the ‘‘true’’ receptor. We thus set up the reverse
experiment: 293T cells were transiently transfected by an ex-
Figure 1. Screening strategy and identification of cDNA clones for the IAPE receptor. A. Scheme of the screening strategy to identify the
protein used as a receptor by the IAPE Env. More technical details are provided in the main text and in the Methods section. LV: lentiviral vector.
B. Scheme representing the cellular localisation of the proteins encoded by the two candidate receptor genes. TMEM9 is an endosomal protein,
whereas Ephrin A4 (encoded by the EFNA4 gene) is expressed at the cell membrane where it can interact with extracellular molecules, including the
EphA proteins. C. Quantification of the mRNA level of the two genes identified as potential receptors for the IAPE elements. The amount of the
corresponding mRNAs was measured by qRT-PCR performed on total RNA extracted from the parental Vero cells as a control, or the five clones found
to be the most sensitive to infection by IAPE pseudotypes (re-numbered from 1 to 5 in this panel). Clones 1,4 and 5 contained an EFNA4 cDNA, and
clones number 2 and 3 a TMEM9 cDNA. The mRNA levels were normalised using the RPLO gene as a reference, and the parental Vero cell line level
was set at 1 for both genes.
doi:10.1371/journal.ppat.1002309.g001
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post transfection, these cells were stained using a soluble, Fc-tagged
Ephrin A4 protein (Ephrin A4-Fc) or a control Fc protein, and a
fluorescentsecondary antibody directed against the Fc domain. The
Ephrin A4-Fc fusion protein has been successfully used to label the
natural ligands of Ephrin A4 [18], and we used it to test if it would
also bind the IAPE Env. As shown in Figure 3B, we could detect by
FACS analysis a strong staining with the Ephrin A4-Fc protein in
the IAPE Env expressing cells, whereas we did not get any staining
with the control Fc protein in the IAPE Env expressing cells and the
control amphotropic MLV (Ampho) Env expressing ones. Thus,
expression oftheIAPE Envbya cellincreasesthespecificbindingof
Ephrin A4. Finally, to definitely demonstrate a physical interaction
between the 2 proteins, we performed a pull-down assay using the
soluble recombinant version of the 2 proteins described above,
together with control proteins (see scheme in Figure 3C): IAPE or
syncytin1 His-tagged SU proteins were mixed with the soluble
Ephrin A4-Fc protein
(or controls) and incubated for 1 hour at 37uC. The Fc-tagged
proteins were then pulled down using protein A-agarose beads, the
beads were washed and the presence of associated SU proteins that
may have co-precipitated was tested by Western blot analysis using
an antibody directed against the Histag. As shown inFigure 3C,the
IAPE SU protein was efficiently pulled down only when incubated
with the Ephrin A4-Fc protein. The syncytin1 control SU protein
was never recovered, indicating that the observed interaction is
specific. This clearly shows that the IAPE Env and Ephrin A4
proteins physically interact. Altogether, these results demonstrate
that the Ephrin A4 protein is a receptor for the IAPE Env.
Other Ephrin A proteins can also be used as receptors by
the IAPE Env
Since the cDNA library we used to identify the receptor of the
IAPE Env was made from Huh7 cells, we tested de facto the human
version of this gene for its receptor activity. However, IAPE
elements are murine endogenous retroviruses and, in the course of
our study, we could not identify a mouse cell line that was
susceptible to infection by IAPE Env-pseudotyped viruses, which
could have indicated the IAPE family was behaving as a xenotropic
retrovirus. We thus decided to test the mouse version of Ephrin A4
for its activity as a receptor, as well as the rat one since it is another
species containing IAPE elements. The cDNAs of these two genes
(see Methods) were cloned into a lentiviral vector that we used to
transduce mouse WOP cells before challenging them with IAPE
Env pseudotypes, as described previously. The results of this
experiment are shown in Figure 4A. As expected for cells not
expressing a functional receptor, the presence of IAPE Env on the
pseudotyped particles does not notably increase the titre as
compared to the no-Env control pseudotypes (average fold increase
in the untreated cells 1.660.5). As expected, the fold increase
Figure 2. Expression of EFNA4 is sufficient to render cells susceptible to infection by IAPE Env pseudotypes. Following the screening
strategy presented in Figure 1, EFNA4 was identified as a potential receptor for the IAPE Env. (A) To confirm this hypothesis, its cDNA (Hs_EFNA4 for
Homo sapiens EFNA4) was re-cloned in a lentiviral vector (LV) and introduced into non-permissive Vero and WOP cells that were then subjected to
infection with IAPE Env pseudotypes containing either the GFP or lacZ genes. (B) For the lacZ-containing pseudotypes, the cells were fixed and
stained with X-Gal to reveal ß-galactosidase activity 3 days post infection. A photo of one representative field for each condition is presented. Note
than in the case of the VSV-G pseudotypes, the supernatant was diluted 200 fold before its use for infection. (C) For the GFP-containing pseudotypes,
the target cells were collected 3 days post infection and subjected to FACS analysis in order to quantify the proportion of GFP-positive cells, allowing
precise calculation of the viral titres (see Methods for details). The results presented in B and C correspond to one representative experiment out of 3.
doi:10.1371/journal.ppat.1002309.g002
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significantly different (unpaired Student test), unlike what is
observed when the cells are transduced with the EFNA4 cDNAs
(fold increases: 2316151, 1667a n d1 6 610 for the human, mouse
and rat EFNA4 genes, respectively; p,0,05 in all 3 cases). This
indicates that the mouse and rat genes can be used as receptors by
the IAPE Env, even though they are around ten times less efficient
than the human version of Ephrin A4. We ensured both by qRT-
PCR (not shown) and stainingfor Ephrin A proteins (Figure S1)that
the expression levels of all constructs were similar and cannot
account for the observed differences. To characterise further the
interaction between the IAPE Env and Ephrin A4 proteins, we used
the soluble His-tagged IAPE SU protein as a probe and stained
WOP cells transduced with the different versions of the EFNA4
gene or a control. We were able to show that the lower receptor
activity we observed with the rodent EFNA4 genes is linked to a
marked decrease in their IAPE Env binding (Figure S1).
As mentioned earlier, Ephrin A4 is a member of a multigenic
family of proteins, the Ephrin As, that are all related GPI-
anchored membrane proteins. We thus decided to test all five
members for their activity as a receptor for the IAPE Env, as well
as the three EFNBs genes, which are also related, but encode
integral membrane proteins (called Ephrin B proteins) (reviewed in
[14,15]). We cloned all 8 mouse cDNAs, introduced them in a
lentiviral vector and tested them as previously described. Figure 4B
shows the IAPE Env pseudotype titres we measured on the
transduced WOP cells, expressed as percentages of the values
obtained with the human version of EFNA4. As shown in the
figure, none of the Ephrin B proteins can be used as a receptor by
the IAPE Env, whereas all five Ephrin A members are functional
Figure 3. Ephrin A4 is a bona fide receptor for the IAPE Env. (A) WOP cells transduced with the EFNA4 gene or a control gene were stained with
the soluble His-tagged IAPE envelope SU subunit (or that of syncytin1 (syn1) as a control) followed by an Alexa488 anti-His antibody and subjected to
FACS analysis. Only the cells transduced with EFNA4 bind the IAPE SU protein, and none of the cells were stained with the control syncytin1-SU. The
expressionlevelofEphrinAproteinsinthetwopopulationswascheckedusingtheEphA2-Fcsolubleprotein(thatcanbindallEphrinAproteins)andare
shown in the small panels on the right. The data presented correspond to one representative experiment out of three. (B) 293T cells were transiently
transfected with an expression vector for IAPE Env, or Ampho MLV Env as a control. At day 2 post transfection, cells were stained with a soluble Ephrin
A4-Fc fusion protein, or a control Fc protein, followed by an Alexa 488 fluorescent anti-Fc antibody before being subjected to FACS analysis. Only the
cells expressing the IAPE Env bind to the recombinant Ephrin A4 protein, The data presented correspond to one representative experiment out of three.
Expression of the two envelope proteins in the transfected cells was checked by Western blot using specific antibodies, as shown on the right. (C) The
soluble recombinant IAPE or syn1 His-tagged SU proteins were tested for interaction with Ephrin A4-Fc (or Fc-only and EphA2 controls) in a pull down
assay as schematised on the left. Pellets were analysed by Western blot using an antibody directed against the His tag (upper part). The only interaction
detected is between Ephrin A4-Fc and IAPE SU. We ensured that the 2 His-tagged SU proteins were produced in similar amount, as shown on the right
(Before IP panel) and that all 3 Fc-tagged proteins were efficiently pulled down by the protein A-agarose beads and recovered in similar amount in the
pellet, as shown on the lower panel (Western blot performed with an anti mouse IgG antibody).
doi:10.1371/journal.ppat.1002309.g003
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A1, 3 and 4) show only limited receptor activity, whereas Ephrin
A2 and Ephrin A5 are nearly as efficient as the human Ephrin A4
protein. As before, we checked that these differences are not due to
variations in the Ephrin expression levels (Figure S1 and qRT-
PCR not shown). Finally, staining of the transduced cells with the
soluble His-tagged IAPE SU protein (Figure S1) indicated that the
mouse Ephrin A2 and Ephrin A5 proteins have a higher affinity
for the IAPE Env compared to the other members of the family for
which we could not detect any specific binding. This could
account for the differences we observed in their receptor activity.
Ephrin A expression pattern in vivo is compatible with
the amplification of the IAPE family via re-infection of the
germline
The experiments above indicate that each of the five members of
the Ephrin A family can be used as a receptor by the IAPE Env in
ex vivo experiments. In a previous study, we demonstrated that the
IAPE elements behave like infectious retroviruses, i.e. they produce
extracellular particles that can infect cells, but they are unable to
undergo intracellular retrotransposition cycles, unlike the related
IAP elements [10]. The mouse genome contains around 200 copies
of this family, indicating that it replicated quite successfully
during rodent evolution. We thus tried to detect expression of the
Ephrin A proteins in the germline of mice, since their presence
should be necessary to account for the amplification of the IAPE
elements through successive re-infections of the germline. First,
we quantified the expression of the five EFNA genes in a panel
of mouse organs using qRT-PCR. We could detect a strong
expression of some of these genes in the embryos and the adult
brain, as expected for genes involved in developmental processes
and axon guidance. We could also detect some expression for
EFNA1, 2, 4 and 5 in the adult ovary, and for EFNA2 and 3 in the
testis (Figure S2). We therefore performed immunohistochemistry
experiments on cryosections of these two organs in order to confirm
these data, using as a probe a recombinant EphA7-Fc protein (a
soluble form of EphA7 that can bind all-Ephrin A proteins, [14]), as
previously described in ref. [19]. As shown in Figure 5, we could see
a specific staining on both organs (panels A, B for the ovary, C, D
for the testis), not obtained with the control ‘‘Fc-only’’ samples
(panels A and C). In the ovary, a strong staining was seen in the
oocytes, as well as to a lower extent in some cells of the growing
follicles. In the testis, we saw also a specific staining of some cells
within the seminiferous tubules. Some of the staining was quite a
distance within the tube (panel D), in a location containing only
germline cells since the somatic Sertoli cells are restricted to the
periphery of the tubes. In both cases, the staining was strong and
rather ubiquitous, which may be due to the fact that the probe can
detect all Ephrin A proteins. We thus did a series of experiments
using antibodies specific for Ephrin A2 or Ephrin A5, which are the
most efficient murine receptors for IAPE Env. As shown in Figure
S3, in the ovary each of these two antibodies gave a specific staining
pattern, with Ephrin A2 being detected mostly in the oocytes and in
the interstitial cells of the ovary stroma whereas Ephrin A5 was
detected mostly in follicle cells, and at a lower level in the oocytes.
This is consistant with the staining observed using the EphA7-Fc
probe that stains all Ephrin A proteins, and confirms that efficient
IAPE receptors are expressed in murine female germ cells. In the
testis, the Ephrin A2 antibody gave a staining similar to that
observed using EphA7-Fc, with spermatozoa stained as well as
some dispersedcells inside the seminiferous tubules. The Ephrin A5
antibody gave a less intense signal, and was found mostly in
spermatozoa. According to these data, the expression pattern of the
Ephrin A proteins, found both in the oocyte and in male germline
cells, is thus compatible with their role in the amplification of the
IAPE family of endogenous retroviruses.
Discussion
In this study, we set to identify the protein used by the
endogenous retroviral family IAPE to enter its target cells. We
used a well-established strategy aiming at complementing a
refractory cell line with a cDNA library in order to identify genes
able to render the cells sensitive to infection. With this method, we
found that the human gene EFNA4 encodes a functional receptor,
and that its mouse homolog, as well as the other members of the
Ephrin A family, also function as receptors for IAPE. By using
recombinant soluble proteins, we could further demonstrate a
direct interaction between Ephrin A4 and IAPE Env, ruling out
any artefact in the screening that could have led us to the
identification of an inducer of the bona fide receptor gene.
Figure 4. Characterisation of several Ephrin A proteins as
receptors for the IAPE Env protein. (A) Comparison of the efficacy
of human (Hs), mouse (Mm) and rat (Rn) Ephrin A4 proteins as receptors
for IAPE Env pseudotypes. WOP cells were transduced with a lentiviral
vector encoding one of the 3 versions of EFNA4, or a control gene. Three
days later, they were challenged with GFP-marked lentiviral particles
pseudotyped with the IAPE Env, the Friend ecotropic Env or no Env
(none). Viral titres were measured by FACS three days post infection. The
results (mean titre 6 standard deviation) are from 5 independent
experiments. (B) Test of the mouse Ephrin A and Ephrin B proteins for
their activity as receptors for the IAPE Env pseudotypes. WOP cells were
transduced with lentiviral vectors containing the different EFNA/B cDNA
or a control gene, and tested for their ability to be infected with IAPE Env
pseudotypes as described in (A). Results (mean 6 standard deviation
calculated from 3–4 independent experiments) are expressed as the
percentage of the titre measured for each gene as compared to that
obtained with the human EFNA4 (Hs_EFNA4, shown on the right).
Asteriks indicate values significantly different (p,0.05) from that
obtained with the untreated cells (unpaired Student test).
doi:10.1371/journal.ppat.1002309.g004
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proteins that are used in vivo as ligands for the multigenic
ephrinA receptor membrane proteins, and are involved in
numerous biological processes ranging from axonal guiding to
insulin regulation or immune processes (reviewed in [14,15,20]).
Over the years, a series of cellular proteins used by retroviruses as
receptors have been identified (reviewed in [21,22] and see
Figure 6A). In most cases, the encoded proteins have been shown
to contain several transmembrane domains. In other cases, the
receptor possesses a single transmembrane domain, like the
transferrin receptor that is used by the Mouse Mammary Tumor
Virus (MMTV)[23]. Butfewoccurrences of GPI-anchored proteins
used as receptors have been reported: there is hyaluronidase 2
(Hyal2), the receptor of Jaagsiekte Sheep RetroVirus (JSRV) [24],
and one of the isoforms of TVA, the receptor used by the avian
sarcoma and leukosis virus (the other isoform being a single
transmembrane protein) [25]. The apparent oddity of the Ephrin A
proteins as receptors, with their GPI-anchor, may mostly be due to
the fact that the majority of the receptors identified so far are used
by gammaretroviral and closely related envelope proteins. All of
them share a common organisation (reviewed in [2,26,27]): their
TM subunit is particularly conserved, especially around the so-
called immunosuppressive domain (CKS17) that is followed by a
CX6–7C(C) motif, and even if their SU subunits are less conserved,
they still possess common features, including a CWLC (consensus
CXXC) motif that is thought to be involved in SU-TM interaction
through the TM CX6–7C(C) motif. This common structure may be
a reason why they all recognise a same class of proteins, containing
multiple membrane spanning domains (Figure 6A). IAPE or JSRV
Env belong to a far less described group of retroviral envelope
proteins, whose only features shared with the gammaretroviral
group are a furin SU-TM cleavage site (R,X,R/K,R) and the TM
CX6–7C(C) motif [26]. No similarity between the 2 groups can be
detected within the SU subunit. It is therefore likely that this second
group of envelope proteins may have evolved to make use of a
different subset of receptors (Figure 6B).
Another unusual feature of the IAPE envelope we uncovered in
this study is its apparent loose recognition specificity, since all 5
mouse Ephrin A proteins can be used as a receptor. These proteins
are all related, but they have evolved independently for millions of
years, which has resulted in a significant divergence (identity rate
between 62 and 68% in amino acids). Accordingly, considering
Figure 5. Expression of the Ephrin A proteins in mouse ovary and testis detected by immunohistochemistry. Ephrin A proteins in these
serial cryosections were labelled using a commercial soluble EphA7-Fc tagged protein (a soluble form of EphA7 that can bind all-Ephrin A proteins) (B
and D), or a Fc-only control protein (A and C). A and B show high magnifications of a Graa ¨fian follicle with the oocyte (filled arrowheads) surrounded
by follicle cells (open arrowheads). C and D show cross-sections of seminiferous tubules, with spermatozoa in the central lumen. Filled arrowheads
point to stained germinal cells located apart from the periphery of the tubule (inset: higher magnification of stained cells).
doi:10.1371/journal.ppat.1002309.g005
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five proteins are all functional receptors. However, this level of
conservation is probably enough to maintain common structural
features enabling recognition of all five proteins by a same
molecule. This is supported by the natural ligands of the Ephrin A
proteins, the EphA receptors, which show a broad specificity too:
most of them can recognise all or most of the Ephrin A proteins,
even though the affinity for one or the other Ephrin A can vary by
more than one log as measured in ex vivo assays (reviewed in
ref. [14]). It is thus not so surprising to have the IAPE envelope
showing the same sort of general family-wide recognition. It is also
in agreement with the observation that the Nipah and Hendrah
viruses can use both Ephrin B2 and Ephrin B3 proteins as their
receptor, even if Ephrin B2 is preferred [28,29]. Interestingly we
could not detect any similarity between the IAPE SU domain of
the envelope (responsible for the recognition of the receptor) and
the EphA proteins, suggesting that the ability to interact with the
Ephrin A proteins was a de novo acquisition by the IAPE
retroviral elements, and not the result of a recombination with a
cellular copy of an EphA gene.
On an evolutionary point of view, the IAPE use of the 5 Ephrin
A proteins as receptors is interesting considering its endogenous
status. Until now among the reported cases, only one or sometimes
two different proteins can be used as a receptor by a given
retroviral Env (reviewed in [21,22]). With all Ephrin A proteins
being functional receptors, the IAPE family seems rather unusual.
Figure 6. Classified retroviral receptors and dendrogram of the corresponding retroviral envelopes. A. Scheme of the three types of
proteins that are used as receptors by various retroviruses. Examples of each type are provided below, with the name of the receptors indicated on
the left followed by the name of the virus(es) using them in brackets. B. Dendrogram of the envelopes listed in A. Those using receptors with multiple
membrane domains are in yellow, single membrane domain in green and GPI anchor in purple.
doi:10.1371/journal.ppat.1002309.g006
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great asset for the amplification and survival of the family. First
because of the very nature of the EFNA genes, which are involved
in a series of developmental processes and are widely expressed
(reviewed in [14,20] and data in Figure 5 and Figures S2 and S3),
particularly very early in the development, when the germline is
still readily accessible to viral particles. This high expression
combined with the ability to infect through any of the five Ephrin
A proteins suggests that the number of possible target cells is quite
high. Second because, with these five proteins being functional
receptors, it seems virtually impossible for the host to evolve so as
to be protected against re-infection of its germline by IAPE viral
particles. Such an escape mechanism is a common theme in host-
pathogen interactions, and indeed has occurred recently in the
mouse lineage, with most modern laboratory mice being protected
from their own xenotropic endogenous proviruses thanks to a
recent point mutation in their unique xpr1 receptor gene, which
renders it non-functional for xenotropic virus entry (reviewed in
[30]). In the case of the IAPE family however, the inactivation of
the five Ephrin A proteins as receptors while maintaining their
physiological function is most certainly an impossible task, and this
could explain why this family was so successful and is still
maintained within the mouse genome concomitantly with its
envelope-less strictly intracellular IAP progeny.
Methods
Plasmids
CMV-driven mammalian expression vectors for the IAPE Env
(IAPE D2*) and the other envelope proteins used as controls have
been described previously [10,31], as well as the plasmids used to
generate lentiviral HIV-1 pseudotypes [32]. New self-inactivating
lentiviral vectors (pSIN) were derived from pHR’SIN-cPPT-SEW
[33] by replacing the GFP open reading frame (BamHI – NotI
fragment) by that of other genes: LacZ gene, hygromycin
resistance gene, Cherry fluorescent protein encoding gene, cDNAs
of EFNA and EFNB genes. The latter were obtained by RT-PCR
performed on purified RNA extracted from mouse embryos
(mouse genes) or the 208F cell line (rat EFNA4). The expression
plasmids for the soluble Fc-tagged versions of Ephrin A4, EphA2
and the Fc-only control were described previously [18]. The vector
used to produce the soluble His-tagged SU IAPE env subunit
was generated by replacing the TM domain in the IAPE Env
expression plasmid by a VHRGSH6 sequence placed just down-
stream from the cleavage site which was changed into an AAAR
sequence. The control plasmid encoding the soluble His-tagged
SU of Syncytin1 was generated as described in ref. [17]. All
fragments generated by PCR were sequenced to ensure that no
mutation had been introduced during this step.
cDNA library
The cDNA library was custom-made by Invitrogen using
mRNA extracted from Huh7 cells, which was reverse-transcribed
and cloned in the pLenti6/V5-Dest lentiviral vector.
Quantitative RT-PCR
Total RNAs were extracted using the RNeasy extraction kit
(Qiagen) and treated with DNase I (Ambion). 1 mg was used for each
RT reaction using the MLV reverse-transcriptase (Applied Biosys-
tems). Quantitative PCR was done using 5 mL of a 1/25 dilution of
the cDNAs in a final volume of 25 mL by using SYBR Green PCR
MasterMix (AppliedBiosystems).PCR was carried outusing an ABI
PRISM 7000 sequence detection system. The efficacy of the PCR
reaction was checked for each primer pair using serial dilutions of a
reference sample and found to be more than 90%. The transcript
levels were normalized relative to the amount of RPLO transcripts
using the DDCt method. Samples were assayed in duplicate.
Cell culture, transfection, virus production and infection
assays
293T, WOP and Vero cells were grown at 37uC and 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% heat-inactivated foetal calf serum (Invitrogen), 100 mg/mL
streptomycin, and 100 U/mL penicillin. Hygromycin selection was
performed for two weeks using 400 u/mL hygromicin B (Calbio-
chem). For transfection, 293T cells were seeded at approximately
20% confluence. The day after seeding, they were transfected using
Fugene 6 (Roche) or JetPrime (Polyplus transfection) following the
manufacturerinstructions, exceptwe used 3 mg totalDNAper6 cm
dish (this quantity was adapted proportionally to the dish surface
when transfections were performed in different scales). The cells
were washed and placed in fresh medium the day after transfection.
For virus production, we used the following ratio for the plasmids:
8.91 (HIV Gag-Pol expressionvector): 1; pSIN lentiviral vector: 1.5;
Env expression vector: 0.3. The viral particles-containing superna-
tants were collected at day 3 post transfection, and passed through
0.45 mm filters before use. Infections were performed by adding
viral supernatants to target cells in the presence of polybrene (8 mg/
mL), and complemented with cyclosporine A (5 mM) in the case of
Vero cells to abrogate TRIM5a–mediated restriction of the HIV1-
derived particles [34]. In some experiments, the infection rates were
increased by subjecting the cells to spinoculation (centrifugation for
2h30 at 1200 g, 25uC) just after adding the viral supernatants (this
step also slightly increased the background infection level measured
with the No Env Pseudotypes). Infection was detected three days
post infection by staining the cells with X-Gal for the LacZ reporter
gene, or by FACS for the GFP reporter gene. In the latter case, we
used samples containing 5–15% GFP positive cells and calculated a
viral titre from the volume of supernatant used for the infection and
the number of target cells that were seeded. The 5–15% window
was chosen to ensure we were still in the linear zone of the infection
curve, where positive cells have only been infected by one particle.
Cell staining and FACS analysis
For the cell staining experiments, we used Fc-tagged soluble
recombinant proteins (Ephrin A4-Fc, EphA2-Fc and the control
Fc-only, described in [18]) and His-tagged soluble Env SU (IAPE-
His and Syncytin1-His) as ‘‘probes’’. These were produced by
293T cells in a serum-free medium (OptiMEM, Invitrogen) after
transient transfection with a CMV-driven mammalian expression
vector using Fugene6 (Roche). The protein-containing superna-
tants were collected at day 2 post transfection and passed through
0.45 mm filters before use. Samples were analysed by Western blot
to ensure the proteins were produced at similar levels in the
supernatants. The cells to be stained (10
6 per sample) were
detached using PBS 5 mM EDTA, washed in PBS and incubated
for 1 h at 37uC in neat supernatant containing the recombinant
protein, washed twice in PBS, 2% FCS, 0.1% sodium azide and
incubated for 30 min with a fluorescent antibody (Alexa 488 Anti
mouse IgG, Molecular Probes or Alexa 488 PentaHis antibody,
Qiagen) at 4uC. They were then washed 3 times in PBS, 2% FCS,
0.1% sodium azide, resuspended in PBS, 0.1% sodium azide and
fixed with paraformaldehyde before FACS analysis.
Pull-down assay and Western blot
Fc-tagged and His-tagged soluble recombinant proteins were
produced as described above. Protease inhibitors (cOmplete
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supernatants containing the recombinant proteins. 700 mL of each
supernatant (His-tagged SU and Fc-tagged protein) were mixed
and incubated for 1 h at 37uC with gentle agitation. Then protein
A-agarose beads (Pierce, 20 mL packed beads per sample) were
washed twice in PBS and saturated in PBS, 0.5% BSA before they
were added to each sample complemented with BSA (0.5% final
concentration). After a 1 h incubation at 37uC with gentle
agitation, the beads were washed 5 times in PBS, Tween 0.1%
before 150 mL of Laemmli buffer containing 10% ß-Mercapto-
ethanol were added to each sample that was then boiled for 5 min.
For Western blot analyses, reduced samples (5 mL of neat
supernatant or 8 mL of the pull-down assay product) denatured in
Laemmli buffer or LDS loading buffer (Invitrogen) were subjected
to SDS-PAGE using gradient precast gels (Novex 4–12% Bis-Tris
gels, Invitrogen). After migration, proteins were transferred onto a
nitrocellulose membrane using a semi dry transfer system. His-
tagged proteins were detected using the Penta-His HRP antibody
(Qiagen), and the Fc-tagged ones using the ECL sheep anti mouse
IgG (HRP-linked F(ab9)2 fragment, Amersham). The antibody
directed against the IAPE Env has been previously described [10],
and the antibody used to detect the amphotropic MLV Env was a
goat anti Rauscher Leukemia Virus gp70 [originally obtained
from the National Cancer Institute, Frederick, MD].
Immunohistochemistry experiments
8–9 week old C57Bl/6 mice were used. The testis and ovaries
were fixed by immersion in 4% paraformaldehyde in 0.1 M sodium
phosphate pH 7 for 5 h, followed by 20%sucrosein PBS overnight.
The tissues were embedded in Tissue-Tek OCT (Sakura) and
sections were cut using a cryostat. Staining of total Ephrin A
proteinswasperformedusingtheEphA7-Fcfusionprotein(stainsall
5 Ephrin A proteins, see [14]) or its control Fc-only protein (10–
25 mg/mL, both purchased from R&D Systems) essentially as
described in ref. [19], except that the blocking was performed in the
presence of rat anti mouse CD16/CD32 used at a 1/50 dilution
(Pharmingen). Stainingof specific Ephrin A proteins was doneusing
either a goat anti mouse Ephrin A2 antibody (R&D systems) or a
rabbit anti Ephrin A5 antibody (Novus Biologicals), following the
recommendations provided. Revelation was done using Alkaline
Phosphatase-linked secondary antibodies (donkey anti-Rabbit IgG
and bovine anti-Goat IgG for Ephrin A2 and Ephrin A5,
respectively, Jackson ImmunoResearch) and NBT/BCIP substrate
(1-Step NBT/BCIP plus Suppressor, Thermo Scientific).
Accession numbers
The sequences we used as references for the cloned EFNA
and EFNB genes are as follows: Hs_EFNA4: NM005227; Rn_
ENFA4: NM001107692, Mm_EFNA1: NM010107, Mm_EFNA2:
NM007909, Mm_EFNA3: NM010108, Mm_EFNA4: NM007910,
Mm_EFNA5: NM207654, Mm_EFNB1: NM010110, Mm_EFNB2:
NM010111, Mm_EFNB3: NM007911.
IAPE-D2* Env sequence can be deduced from the IAPE D2
provirus [10]: AC131339, pos: 143356–35028. Similar results
were obtained using IAPE-D1 Env whose sequence can be
deduced from AC123738, pos: 161181–152862.
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Supporting Information
Figure S1 Characterisation of WOP cells transduced with the
different EFNA and EFNB genes tested in this study. The WOP
cells transduced with the series of EFNA/EFNB cDNA-containing
LVs and tested for their ability to be infected by IAPE Env
pseudotypes (see Figure 4) were stained with different soluble
proteins and subjected to FACS analysis. Staining with the EphA2-
Fc protein (in green) indicates the level of Ephrin A protein
expression. Cells transduced with EFNAs (Hs_EFNA4, Rn_EFNA4
or each of the 5 mouse EFNAs) show a strong increase in EphA2-Fc
staining, indicating that the transduced EFNA cDNAs are all highly
and equally expressed. There is also some EphA2-Fc staining
observed with the EFNB1 and EFNB2 transduced cells (but much
weaker), indicating that EphA2 can to some extent cross-label these
Ephrin B proteins. Staining with the IAPE SU-His protein (red) was
used to test whether the different Ephrin A and B proteins can
interact with IAPE Env. The 3 ‘‘best’’ EFNAcDNA that can render
WOP cells infectable by IAPE Env pseudotypes (Hs_EFNA4,
Mm_EFNA2 and Mm_EFNA5) are the only ones that can bind the
IAPE SU-His protein, suggesting they have a stronger affinity for
the IAPE envelope than the other EFNA genes tested. The control
protein sample shown in the figure (filled in light grey) corresponds
to cells stained with a control His-tagged soluble protein and an
anti-His Alexa 488 secondary antibody; staining with a Fc-only
protein and the corresponding Alexa 488 secondary antibody gave
the same profile (not shown).
(TIF)
Figure S2 Quantification of the EFNA genes expression in a
panel of mouse organs. The RNA levels of the 5 mouse EFNA
genes were measured in a panel of mouse tissues (from 8–9 week
old C57Bl/6 mice, except for embryos and placentas that were
aged 11.5 d) by quantitative RT-PCR. Reactions were performed
essentially as described in the Methods section, except that in this
case the transcript levels for each gene were measured using serial
dilutions of a reference sample as an internal standard. The
transcript levels in the different tissues were normalized relative to
the amount of RPLO transcripts, and are expressed for each
EFNA gene as percentage of the maximum expression detected.
(TIF)
Figure S3 Detection of the Ephrin A2 and Ephrin A5 proteins
by immunohistochemistry. Expression in mouse ovary (A–D) and
testis (E–H). Ephrin A2 (B and F) and Ephrin A5 (D and H)
proteins in these serial cryosections were labelled using commer-
cial antibodies specific for each protein or, as a negative control,
using an irrelevant primary antibody that was generated in the
same species and subjected to similar purification (control for
Ephrin A2 staining, A and E)) or the secondary antibody only
(control for Ephrin A5 staining, C and G). Abbreviations: oocyte:
Oo, follicular cells: FC, interstitial cells: IC, spermatozoa: Sp.
(TIF)
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